The TAZ-CAMTA1 Fusion Protein Promotes Tumorigenesis via Connective Tissue Growth Factor and Ras–MAPK Signaling in Epithelioid Hemangioendothelioma | Clinical Cancer Research | American Association for Cancer Research https://t.co/MMtIAYYXm6
RRIDs were included in the Clinical Cancer Research paper "The TAZ-CAMTA1 Fusion Protein Promotes Tumorigenes…" (https://t.co/OF5PJUjw4r). Thank you for making your #methodsmatter. #reproducibility
Hippo pathway targeted by trametinib. Expecting trial results for our epithelial hemangioendothelioma patients. #EHE @GreekSarc @EllokGr
RT @TheLamarLab: Thrilled to share our collaborative paper with the Rubin Lab published in @CCR_AACR Link: https://t.co/Rif2JXjXgy. This wo…